Tinavi Medical Technologies Co (SHSE:688277) Marketable Securities: ¥17.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688277 Tinavi Medical Technologies Co Ltd SHSE:688277
78 GF Score
Price ¥15.54
GF Value ¥17.57
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Tinavi Medical Technologies Co Marketable Securities?

Tinavi Medical Technologies Co SHSE:688277 78 Marketable Securities is ¥17.0 Mil as of Jun. 2026. GuruFocus rates SHSE:688277 with a GF Score™ of 78/100 and a GF Value™ of ¥17.57 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Tinavi Medical Technologies Co's Marketable Securities for the quarter that ended in Jun. 2026 was ¥17.0 Mil.

Tinavi Medical Technologies Co's annual Marketable Securities declined from Dec. 2023 (¥50.0 Mil) to Dec. 2024 (¥0.0 Mil) but then increased from Dec. 2024 (¥0.0 Mil) to Dec. 2025 (¥41.6 Mil).

Tinavi Medical Technologies Co  (SHSE:688277) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Tinavi Medical Technologies Co Marketable Securities Related Terms

Tinavi Medical Technologies Co Marketable Securities Historical Data

* Premium members only.

The historical data trend for Tinavi Medical Technologies Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tinavi Medical Technologies Co Marketable Securities Chart

Tinavi Medical Technologies Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 120.63 40.20 50.04 0.00 41.65

Tinavi Medical Technologies Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 76.02 110.57 41.65 33.62 17.01
SHSE:688277
78GF Score
Tinavi Medical Technologies Co Ltd SHSE:688277
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tinavi Medical Technologies Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ¥17.0 Mil mean?
Tinavi Medical Technologies Co (SHSE:688277) has a Marketable Securities of ¥17.0 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Tinavi Medical Technologies Co and its competitors.
Is Tinavi Medical Technologies Co's Marketable Securities too high?
Tinavi Medical Technologies Co's current Marketable Securities is ¥17.0 Mil. Overall, Tinavi Medical Technologies Co has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Tinavi Medical Technologies Co's Marketable Securities compare to ISRG and BDX?
Tinavi Medical Technologies Co's Marketable Securities of ¥17.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Devices & Instruments company?
A good Marketable Securities depends on the Medical Devices & Instruments industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Tinavi Medical Technologies Co and its competitors. Tinavi Medical Technologies Co's current Marketable Securities is ¥17.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tinavi Medical Technologies Co stock overvalued right now?
Based on GuruFocus' analysis, Tinavi Medical Technologies Co (SHSE:688277) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥17.57, compared to a current price of ¥15.54 — trading 11.6% below its estimated fair value. The current Marketable Securities is ¥17.0 Mil. Tinavi Medical Technologies Co's overall GF Score™ is 78/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Tinavi Medical Technologies Co (SHSE:688277), the current Marketable Securities is ¥17.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tinavi Medical Technologies Co (SHSE:688277) Overvalued in 2026?

Based on GuruFocus' analysis, Tinavi Medical Technologies Co stock appears to be undervalued. The current stock price of ¥15.54 is trading 11.6% below its estimated GF Value™ of ¥17.57. GuruFocus considers Tinavi Medical Technologies Co to be Modestly Undervalued.

Key valuation signals for SHSE:688277:

  • Marketable Securities: ¥17.0 Mil
  • GF Value™: ¥17.57 vs. price of ¥15.54 (11.6% below fair value)
  • GF Score™: 78/100 with 4 warning signs

No single metric tells the full story. See the SHSE:688277 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tinavi Medical Technologies Co Business Description

Address Jianfeng Road South Extension, Building 2, Courtyard 8, Jinyu Science and Technology Park, Zhongguancun Xisanqi, Haidian District, Beijing, CHN, 100096
Tinavi Medical Technologies Co Ltd is engaged in the Research, development, production, sales and service of orthopedic surgical navigation and positioning robots.
78GF Score

Get the complete analysis for SHSE:688277

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥15.54
Price
¥17.57
GF Value